Treatment

12 07, 2022

Microbiome-Based Hypothesis on Ivermectin’s Mechanism in COVID-19: Ivermectin Feeds Bifidobacteria to Boost Immunity

July 12, 2022|Ivermectin, Research, Treatment, World|

Ivermectin is an anti-parasitic agent that has gained attention as a potential COVID-19 therapeutic. It is a compound of the type Avermectin, which is a fermented by-product of Streptomyces avermitilis. Bifidobacterium is a member of the same phylum as Streptomyces spp., suggesting it may have a symbiotic relation with Streptomyces.

30 06, 2022

Successful management of intracranial hemorrhage in patient with COVID-19 vaccine-induced immune thrombotic thrombocytopenia and cerebral venous thrombosis: A case report

June 30, 2022|Research, Treatment, Vax Damage, World|

To the editor,

The COVID-19 vaccine has become widely available worldwide due to the 2019 Coronavirus disease (COVID-19) pandemic. AstraZeneca’s COVID-19 (ChAdOx1) vaccine has been known to cause vaccine-induced immune thrombotic thrombocytopenia (VITT), which is a medical term used to describe the development of low platelet counts following vaccination. […]